These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 7030325
1. Antibody-mediated targeting of alpha-1,4-glucosidase-albumin polymers to rat hepatocytes. A model for enzyme therapy. Poznansky MJ, Bhardwaj D. Biochem J; 1981 Apr 15; 196(1):89-93. PubMed ID: 7030325 [Abstract] [Full Text] [Related]
2. alpha1,4-Glucosidase-albumin polymers: in vitro properties and advantages for enzyme replacement therapy. Poznansky MJ, Bhardwaj D. Can J Physiol Pharmacol; 1980 Mar 15; 58(3):322-5. PubMed ID: 6991081 [Abstract] [Full Text] [Related]
3. alpha-Glucosidase-albumin conjugates: effect of chronic administration in mice. Allen TM, Murray L, Bhardwaj D, Poznansky MJ. J Pharmacol Exp Ther; 1985 Jul 15; 234(1):250-4. PubMed ID: 3891969 [Abstract] [Full Text] [Related]
4. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP, Kamphoven JH, van den Hout HJ, Severijnen LA, van Doorn PA, Reuser AJ, van der Ploeg AT. Muscle Nerve; 2003 Jun 15; 27(6):743-51. PubMed ID: 12766987 [Abstract] [Full Text] [Related]
5. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs. Higuchi T, Kawagoe S, Otsu M, Shimada Y, Kobayashi H, Hirayama R, Eto K, Ida H, Ohashi T, Nakauchi H, Eto Y. Mol Genet Metab; 2014 May 15; 112(1):44-8. PubMed ID: 24642446 [Abstract] [Full Text] [Related]
6. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MC, Vulto AG, Van Doorn PA, De Jong G, Hop W, Smit GP, Shapira SK, Boer MA, van Diggelen OP, Reuser AJ, Van der Ploeg AT. Ann Neurol; 2004 Apr 15; 55(4):495-502. PubMed ID: 15048888 [Abstract] [Full Text] [Related]
7. Enzyme inhibitory assay using monoclonal antibody against acid alpha-D-glucosidase in prenatal diagnosis to identify homozygotes of Pompe's disease. Wei CY, Yeh GP, Chen HF, Wang LY, Lin CY. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992 Apr 15; 33(2):104-11. PubMed ID: 1514400 [Abstract] [Full Text] [Related]
8. Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. Van der Ploeg AT, Kroos MA, Willemsen R, Brons NH, Reuser AJ. J Clin Invest; 1991 Feb 15; 87(2):513-8. PubMed ID: 1991835 [Abstract] [Full Text] [Related]
9. Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies. Lu IL, Lin CY, Lin SB, Chen ST, Yeh LY, Yang FY, Au LC. Gene Ther; 2003 Oct 15; 10(22):1910-6. PubMed ID: 14502220 [Abstract] [Full Text] [Related]
10. Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats. Johansson AG, Løvdal T, Magnusson KE, Berg T, Skogh T. Hepatology; 1996 Jul 15; 24(1):169-75. PubMed ID: 8707258 [Abstract] [Full Text] [Related]
11. Preparation of monoclonal antibodies against acid alpha-D-glucosidase for study of Chinese glycogenosis type II patients. Lin CY, Lee SY, Chang ZN, Su SN, Hwang B, Han SH. Hybridoma; 1992 Aug 15; 11(4):493-505. PubMed ID: 1398685 [Abstract] [Full Text] [Related]
13. Immunohistochemical localization of acid alpha-glucosidase in rat liver. Iwamasa T, Ninomiya N, Hamada T, Fukuda S. J Histochem Cytochem; 1982 Apr 15; 30(4):378-84. PubMed ID: 7037944 [Abstract] [Full Text] [Related]
14. An electron microscopic and biochemical study of the effects of glucagon on newborn rat hepatocytes. Kotoulas OB. Bull Assoc Anat (Nancy); 1984 Jun 15; 68(201):189-97. PubMed ID: 6399004 [Abstract] [Full Text] [Related]
15. Glycogen storage disease type II (Pompe's disease): the first biochemical evidence in Thailand. Rangdaeng S, Scollard DM, Srichairatanakol S, Sutthachit M, Phornphutkul C. J Med Assoc Thai; 1987 Sep 15; 70(9):536-42. PubMed ID: 2960768 [No Abstract] [Full Text] [Related]
16. [Treatment of Pompe's disease with recombinant enzymes]. Van Hove JL. Verh K Acad Geneeskd Belg; 1998 Sep 15; 60(4):347-57. PubMed ID: 9883081 [Abstract] [Full Text] [Related]
17. IgG immune complex binding to and activation of liver cells. An in vitro study with IgG immune complexes, Kupffer cells, sinusoidal endothelial cells and hepatocytes. Johansson AG, Sundqvist T, Skogh T. Int Arch Allergy Immunol; 2000 Apr 15; 121(4):329-36. PubMed ID: 10828724 [Abstract] [Full Text] [Related]
18. [Enzyme replacement therapy in Pompe's disease]. Merk T, Wibmer T, Schumann C, Krüger S. Med Klin (Munich); 2007 Jul 15; 102(7):570-3. PubMed ID: 17634875 [Abstract] [Full Text] [Related]
19. Angiocardiographic and enzyme studies in a patient with type II glycogenosis (Pompe's disease). A case report. Bonnici F, Shapiro R, Joffe HS, Petersen EM. S Afr Med J; 1980 Nov 22; 58(21):860-2. PubMed ID: 6777881 [Abstract] [Full Text] [Related]
20. Enzyme-albumin polymers. New approaches to the use of enzymes in medicine. Poznansky MJ. Appl Biochem Biotechnol; 1984 Nov 22; 10():41-56. PubMed ID: 6395807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]